Literature DB >> 22162309

CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material.

Oscar Krijgsman1, Danielle Israeli, Josien C Haan, Hendrik F van Essen, Serge J Smeets, Paul P Eijk, Renske D M Steenbergen, Klaas Kok, Sabine Tejpar, Gerrit A Meijer, Bauke Ylstra.   

Abstract

Formalin-fixed, paraffin-embedded (FFPE) archival tissue is an important source of DNA material. The most commonly used technique to identify copy number aberrations from chromosomal DNA in tumorigenesis is array comparative genomic hybridization (aCGH). Although copy number analysis using DNA from FFPE archival tissue is challenging, several research groups have reported high quality and reproducible DNA copy number results using aCGH. Aim of this study is to compare the commercially available aCGH platforms suitable for high-resolution copy number analysis using FFPE-derived DNA. Two dual channel aCGH platforms (Agilent and NimbleGen) and a single channel SNP-based platform (Affymetrix) were evaluated using seven FFPE colon cancer samples, and median absolute deviation (MAD), deflection, signal-to-noise ratio, and DNA input requirements were used as quality criteria. Large differences were observed between platforms; Agilent and NimbleGen showed better MAD values (0.13 for both) compared with Affymetrix (0.22). On the contrary, Affymetrix showed a better deflection of 0.94, followed by 0.71 for Agilent and 0.51 for NimbleGen. This resulted in signal-to-nose ratios that were comparable between the three commercially available platforms. Interestingly, DNA input amounts from FFPE material lower than recommended still yielded high quality profiles on all platforms. Copy number analysis using DNA derived from FFPE archival material is feasible using all three high-resolution copy number platforms and shows reproducible results, also with DNA input amounts lower than recommended.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162309     DOI: 10.1002/gcc.21920

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

1.  Guidelines for cytogenetic investigations in tumours.

Authors:  Rosalind J Hastings; Nick Bown; Maria G Tibiletti; Maria Debiec-Rychter; Roberta Vanni; Blanca Espinet; Nadine van Roy; Paul Roberts; Eva van den Berg-de-Ruiter; Alain Bernheim; Jacqueline Schoumans; Steve Chatters; Zuzana Zemanova; Marian Stevens-Kroef; Annet Simons; Sverre Heim; Marta Salido; Bauke Ylstra; David R Betts
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

2.  Detection limits of DNA copy number alterations in heterogeneous cell populations.

Authors:  Oscar Krijgsman; Daniëlle Israeli; Hendrik F van Essen; Paul P Eijk; Michel L M Berens; Clemens H M Mellink; Aggie W Nieuwint; Marjan M Weiss; Renske D M Steenbergen; Gerrit A Meijer; Bauke Ylstra
Journal:  Cell Oncol (Dordr)       Date:  2012-11-02       Impact factor: 6.730

3.  Bisulfite-Based DNA Methylation Analysis from Recent and Archived Formalin-Fixed, Paraffin Embedded Colorectal Tissue Samples.

Authors:  Alexandra Kalmár; Bálint Péterfia; Péter Hollósi; Barnabás Wichmann; András Bodor; Árpád V Patai; Andrea Schöller; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2015-05-20       Impact factor: 3.201

4.  Absence/presence calling in microarray-based CGH experiments with non-model organisms.

Authors:  Martijs J Jonker; Wim C de Leeuw; Marino Marinković; Floyd R A Wittink; Han Rauwerda; Oskar Bruning; Wim A Ensink; Ad C Fluit; C H Boel; Mark de Jong; Timo M Breit
Journal:  Nucleic Acids Res       Date:  2014-04-25       Impact factor: 16.971

5.  Human pontine glioma cells can induce murine tumors.

Authors:  Viola Caretti; A Charlotte P Sewing; Tonny Lagerweij; Pepijn Schellen; Marianna Bugiani; Marc H A Jansen; Dannis G van Vuurden; Anna C Navis; Ilona Horsman; W Peter Vandertop; David P Noske; Pieter Wesseling; Gertjan J L Kaspers; Javad Nazarian; Hannes Vogel; Esther Hulleman; Michelle Monje; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2014-04-29       Impact factor: 17.088

6.  Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.

Authors:  Rachael Thomas; Luke Borst; Daniel Rotroff; Alison Motsinger-Reif; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Chromosome Res       Date:  2014-03-06       Impact factor: 5.239

7.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

Authors:  Ilari Scheinin; Daoud Sie; Henrik Bengtsson; Mark A van de Wiel; Adam B Olshen; Hinke F van Thuijl; Hendrik F van Essen; Paul P Eijk; François Rustenburg; Gerrit A Meijer; Jaap C Reijneveld; Pieter Wesseling; Daniel Pinkel; Donna G Albertson; Bauke Ylstra
Journal:  Genome Res       Date:  2014-09-18       Impact factor: 9.043

8.  Focus on 16p13.3 Locus in Colon Cancer.

Authors:  Evi Mampaey; Annelies Fieuw; Thalia Van Laethem; Liesbeth Ferdinande; Kathleen Claes; Wim Ceelen; Yves Van Nieuwenhove; Piet Pattyn; Marc De Man; Kim De Ruyck; Nadine Van Roy; Karen Geboes; Stéphanie Laurent
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

9.  High fidelity copy number analysis of formalin-fixed and paraffin-embedded tissues using Affymetrix Cytoscan HD chip.

Authors:  Yan P Yu; Amantha Michalopoulos; Ying Ding; George Tseng; Jian-Hua Luo
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.

Authors:  Anne Vincent-Salomon; Vanessa Benhamo; Eléonore Gravier; Guillem Rigaill; Nadège Gruel; Stéphane Robin; Yann de Rycke; Odette Mariani; Gaëlle Pierron; David Gentien; Fabien Reyal; Paul Cottu; Alain Fourquet; Roman Rouzier; Xavier Sastre-Garau; Olivier Delattre
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.